Passive Dividend

Vanguard International Dividend Appreciation Index Fund

Vanguard International Dividend Appreciation Index Fund (the “Fund”) seeks to track the performance of a benchmark index that measures the investment return of non-U.S. companies that have a history of increasing dividends.

$46.98

Key Metrics

TER 0.16% per year
Distribution policy Distributing
Fund size USD 9,444 M
Inception date March 2, 2016
Holdings 361
Fund currency USD
Fund domicile US
Provider Vanguard
For full official fund details, factsheets, and holdings, visit investor.vanguard.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
International Dividend Appreciation Index Fund VIAAX
Fund Size
$9.45B
Dividend
2.1%
Fees
0.16%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.04%
Morningstar Total Stock Market Index Fund VITSX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
Morningstar Total Stock Market Index Fund VSMPX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.02%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
View 1342 similar ETFs →

Historical Return

Last updated: Oct 15, 2026
1 Year +1.4% +2.1% Div
3 Years (avg.) +0.5% +2.1% Div
5 Years (avg.) +0.3% +2.1% Div

Risk & Analysis Metrics

Last updated: Oct 15, 2026

Volatility

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Max Drawdown

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Sharpe Ratio

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Distributions

*by ETF Portfolio Weight Last updated: Oct 15, 2026

Profit Margin Distribution

< 0%
5%
1y 3y N/A N/A
0 - 5%
4%
1y 3y N/A N/A
5 - 10%
21%
1y 3y N/A N/A
10 - 15%
15%
1y 3y N/A N/A
15 - 20%
31%
1y 3y N/A N/A
20 - 30%
18%
1y 3y N/A N/A
30 - 40%
5%
1y 3y N/A N/A
> 40%
2%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
5%
1y 3y N/A N/A
0 - 10
5%
1y 3y N/A N/A
10 - 15
17%
1y 3y N/A N/A
15 - 20
20%
1y 3y N/A N/A
20 - 25
18%
1y 3y N/A N/A
25 - 35
27%
1y 3y N/A N/A
35 - 50
2%
1y 3y N/A N/A
> 50
7%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.2%
1y 3y N/A N/A
Large Cap
24.2%
1y 3y N/A N/A
Mega Cap
75.6%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Oct 15, 2026
34.8% Top 5 Holdings
61.5% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
RY Royal Bank Of Canada
8.3%
MUFG Mitsubishi UFJ Financial Group, Inc.
8.0%
NSRGY Nestlé SA
6.4%
NVS Novartis AG
6.1%
TD Toronto Dominion Bank
6.0%

Latest News

about 1 month ago • benzinga.com

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics Inc. (NASDAQ:DYN) stock is trading lower on Tuesday in reaction to Novartis AG's (NYSE:NVS) data from the global Phase 3 HARBOR s...

about 1 month ago • 247wallst.com

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) h...

about 1 month ago • reuters.com

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' treatment for a muscle-wasting disorder failed in a trial, fueling inves...

Sectors

Finance and Insurance 22.7%
Manufacturing 11.2%
Health Technology 7.1%
Information 4.9%
Consumer Non-Durables 4.1%
Transportation and Warehousing 1.4%
Professional, Scientific, and Technical Services 0.8%
Retail Trade 0.8%
Administrative and Support and Waste Management and Remediation Services 0.7%
Mining, Quarrying, and Oil and Gas Extraction 0.7%
Healthcare 0.6%
Electronic Technology 0.6%
Wholesale Trade 0.6%
Utilities 0.5%
Accommodation and Food Services 0.4%
Real Estate and Rental and Leasing 0.1%
Energy 0.0%
Other 42.6%

Countries

Japan 31.1%
Canada 21.8%
Switzerland 14.0%
Germany 6.2%
United Kingdom 5.1%
France 3.2%
India 3.2%
Spain 2.6%
Denmark 2.5%
Hong Kong 1.8%
Australia 1.4%
Sweden 1.3%
Belgium 0.9%
United States 0.8%
Other 0.6%
Italy 0.4%
Ireland 0.4%
Netherlands 0.4%
China 0.4%
Mexico 0.4%
Indonesia 0.3%
Taiwan (Province of China) 0.3%
Korea (the Republic of) 0.3%
New Zealand 0.3%
Thailand 0.2%
Finland 0.1%
Norway 0.0%
Colombia 0.0%
South Africa 0.0%
Saudi Arabia 0.0%
Turkey 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 42 investments below

42 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $380.49B
P/E Ratio 17.2
Dividends 2.4%
Total Investment $451.46M
Weight 4.78%

Loading details…

Loading details…

Market Cap $237.26B
P/E Ratio 26.3
Dividends 4.1%
Total Investment $345.95M
Weight 3.66%

Loading details…

Market Cap $273.23B
P/E Ratio 21.8
Dividends 3.1%
Total Investment $329.1M
Weight 3.48%

Loading details…

Market Cap $299.2B
P/E Ratio 17.5
Dividends 2.7%
Total Investment $327.72M
Weight 3.47%

Loading details…

Market Cap $352.94B
P/E Ratio 23.3
Dividends 2.7%
Total Investment $325.94M
Weight 3.45%

Loading details…

Market Cap $250.27B
P/E Ratio 28.0
Dividends 1.3%
Total Investment $305.78M
Weight 3.24%

Loading details…

Market Cap $169.04B
P/E Ratio 31.6
Dividends 1.6%
Total Investment $298.17M
Weight 3.16%

Loading details…

Loading details…

Market Cap $1.13T
P/E Ratio 9.7
Dividends 4.6%
Total Investment $246.61M
Weight 2.61%

Loading details…

Market Cap $25.42T
P/E Ratio 32.0
Dividends 1.0%
Total Investment $243.14M
Weight 2.57%

Loading details…

Market Cap $22.4T
P/E Ratio -103.8
Dividends 0.8%
Total Investment $235.11M
Weight 2.49%

Loading details…

Market Cap $14.98T
P/E Ratio 19.3
Dividends 44.7%
Total Investment $161.23M
Weight 1.71%

Loading details…

Loading details…

Market Cap $14.51T
P/E Ratio 54.8
Dividends 0.9%
Total Investment $137.55M
Weight 1.46%

Loading details…

Loading details…

Market Cap $63.08B
P/E Ratio 21.6
Dividends 2.5%
Total Investment $101.91M
Weight 1.08%

Loading details…

Market Cap $59.95B
P/E Ratio 25.5
Dividends 1.4%
Total Investment $91.82M
Weight 0.97%

Loading details…

Loading details…

Loading details…